The natural history of vascular disease in homocystinuria and the effects of treatment.
about
The effect on endothelial function of vitamin C during methionine induced hyperhomocysteinaemiaEffect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans.Homocysteine-lowering treatment: an overviewHomocysteine--a novel risk factor for vascular diseaseActivation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70Protein homeostasis disorders of key enzymes of amino acids metabolism: mutation-induced protein kinetic destabilization and new therapeutic strategies.Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities StudiesHomocystinuria: Challenges in diagnosis and managementTotal homocysteine and cardiovascular disease.Corrective effects of hepatotoxicity by hepatic Dyrk1a gene delivery in mice with intermediate hyperhomocysteinemia.Molecular characterization of a cystathionine beta-synthase gene, CBS1, in Magnaporthe grisea.Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.Hyperhomocysteinaemia in patients with peripheral arterial occlusive disease.Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype.Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency.An indirect response model of homocysteine suppression by betaine: optimising the dosage regimen of betaine in homocystinuria.DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.Folate improves endothelial function in patients with coronary heart disease.A review of risk factors for stroke in patients with chronic kidney diseaseHomocysteine, vitamin B6 and the risk of recurrent venous thromboembolism.Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults.Are B vitamins a risk factor for venous thromboembolism? Yes.Is there a causal role for homocysteine concentration in blood pressure? A Mendelian randomization study.Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia.Functional Outcome After Lower Limb Amputation: Is Hyperhomocysteinemia a Predictive Factor?: An Observational Study.Cystathionine β-synthase-deficient mice thrive on a low-methionine diet.Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency.Correction of cystathionine β-synthase deficiency in mice by treatment with proteasome inhibitors.Isolated remethylation disorders: do our treatments benefit patients?Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies.Oxidative Stress in Homocystinuria Due to Cystathionine ß-Synthase Deficiency: Findings in Patients and in Animal Models.Acute myocardial infarction in a young patient with hyperhomocysteinaemia.Effects of heparin on the production of homocysteine-induced extracellular matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells.Smoking and atherosclerotic cardiovascular disease: part II: role of cigarette smoking in cardiovascular disease development.Hyperhomocysteinemia and C677T MTHFR genotype in patients with retinal vein thrombosis.Cardiovascular disease-risk factors in middle-aged osteopaenic women treated with calcium alone or combined to three nutrients essential to artery and bone collagen.The molecular basis of cystathionine beta-synthase deficiency in Australian patients: genotype-phenotype correlations and response to treatment.Familial hyperhomocysteinemia: multiple venous thrombosis in four generations of a family.
P2860
Q24800878-92045054-DA22-4042-ABCB-A03115392905Q24810064-6C0CA1DA-A9C3-419B-AD9D-193D6CA10160Q28190121-FB0326F6-071B-441F-9581-6CE6032FA7E6Q28353061-3E9086EE-1D74-4E93-8F8F-672A5EF12A7DQ28472376-C4BA428D-7AB3-4320-A9B8-36FEB49E90F4Q30355120-A2B63502-C27A-4EE4-A97E-5352710BA9E4Q33340170-C3F74D62-E4E0-483F-A8FE-E0440E1AE055Q33697408-9AAD4BA0-9ACF-4F1C-8EEF-15A0FD212879Q33785883-26F97FF1-48AF-4876-AF19-24BAC5F6F3EEQ33799086-752A756D-378C-4EBD-836E-D03E1225ADBFQ33905013-4B8A5725-5DC1-401C-A44B-5A7F950E01B3Q34038098-55530427-73CB-4F9A-BCD2-58D3F5196BBCQ34160359-90F82B0B-D7B0-4426-9E32-0029307DDCD1Q34390750-1F9AB88F-20EF-42A6-A80E-5B6A9A51D478Q34395808-EB87FA01-DB14-44EF-955C-712B5EDD720FQ34515070-D6A2F0C3-C5B6-4A20-8B05-B7CD1554AC85Q34521242-FC7405CE-D59A-409A-9E49-4D30609FB3F4Q34526733-26476C46-FD5D-4D9E-B258-0FDB14690E91Q35600410-5A65E6DE-1517-4772-A870-3F4AC590D396Q35600457-77B97844-514D-4ACB-B9AC-A0BB4EACBE8FQ35865224-EE91064E-B161-432C-AC61-6471EF4E4D03Q36030476-1404AFF8-8644-417B-8519-B9D16487BB3BQ36265878-D0AAFBFE-B396-4B40-B9CE-5CD0D53A758BQ36371678-E67209A1-D2C1-4324-93EE-AC99D0453BCCQ36405825-CE5D8C31-D513-45BD-A7D1-B38C95380DB8Q37123978-A93C42A4-846F-43AB-A464-8E635AFB9B56Q37225950-648EC8E3-021C-45F4-ACAD-C0B8AE12C5DFQ37503715-6E016AB7-5190-4B6A-89D4-B2BFE44AFBC1Q37547501-BF609363-FEB0-476B-84F9-D55165DEEE5FQ37615678-F85D6E88-DB74-4F7A-830B-A3C26E4138AAQ37758544-94C2E7AB-9F13-4332-8506-CDE2E67A9ACCQ38022447-502D7D5E-E3ED-48C8-94CA-4983AC5BAED6Q39160743-EBF1F8E7-784B-4953-8CCB-568F54A4FE6AQ41837097-9CF5C72E-E680-4534-B0B6-6433E2C298CDQ41879658-857A524F-21AD-4918-B991-CA6BA9764DAFQ43061592-8AB8F796-0938-4730-B865-2E6A8B32FC93Q43262218-C515E917-2CEA-47A2-88A2-DD9DF94E5470Q43609380-B96317FA-4125-4F4D-A73A-70E714830F68Q44069015-35BC075B-84BE-464F-B96A-100095DFF306Q44360523-920D55C6-6EFB-4849-8E62-F0C58D3D2062
P2860
The natural history of vascular disease in homocystinuria and the effects of treatment.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
The natural history of vascular disease in homocystinuria and the effects of treatment.
@ast
The natural history of vascular disease in homocystinuria and the effects of treatment.
@en
The natural history of vascular disease in homocystinuria and the effects of treatment.
@nl
type
label
The natural history of vascular disease in homocystinuria and the effects of treatment.
@ast
The natural history of vascular disease in homocystinuria and the effects of treatment.
@en
The natural history of vascular disease in homocystinuria and the effects of treatment.
@nl
prefLabel
The natural history of vascular disease in homocystinuria and the effects of treatment.
@ast
The natural history of vascular disease in homocystinuria and the effects of treatment.
@en
The natural history of vascular disease in homocystinuria and the effects of treatment.
@nl
P356
P1476
The natural history of vascular disease in homocystinuria and the effects of treatment.
@en
P2093
P2888
P304
P356
10.1023/A:1005373209964
P577
1997-06-01T00:00:00Z
P6179
1052884636